Our Mission & Vision
JHTV aims to maximize the impact of Johns Hopkins University’s research excellence by facilitating the translation and commercialization of discoveries into accessible technologies, products and services that benefit society.
Proven Track Record
Since 2014, JHTV has been advancing innovation ecosystems and developing tomorrow's solutions for today's biggest challenges.
43,000 SQ Ft
of incubator space
available for licensing
150+ Commercial Startups
in venture funding raised by portfolio companies
30+ Active research collaborations
2023 annual report
Delfi Diagnostics, Inc.
In 2022, Cancer Discovery published positive liver cancer detection data which demonstrates the promise of Delfi Diagnostics' high-performance, accessible liquid biopsy platform in a new tumor type. Delfi also announced a Series B funding of $225 million to continue developing a new class of high-performance, accessible liquid biopsy tests for early cancer detection and monitoring.